Table 3. Instances and syndromic groups in the unmapped subset of the data.
| Syndromicgroup | Instances | Percentageof total | Cumulativepercentage |
| Mastitis | 38,934 | 73.26% | 73.26% |
| Nonspecific | 7,667 | 14.43% | 87.68% |
| GIT | 2,857 | 5.38% | 93.06% |
| Respiratory | 1,309 | 2.46% | 95.52% |
| Reproductive | 732 | 1.38% | 96.90% |
| Abortion | 553 | 1.04% | 97.94% |
| Musculoskeletal | 232 | 0.44% | 98.38% |
| Haematopoietic | 231 | 0.43% | 98.81% |
| Hepatic | 129 | 0.24% | 99.06% |
| Urinary | 125 | 0.24% | 99.29% |
| Envir. samples | 109 | 0.21% | 99.50% |
| Systemic | 98 | 0.18% | 99.68% |
| Nervous | 67 | 0.13% | 99.81% |
| Circulatory | 57 | 0.11% | 99.91% |
| Eyes and ears | 38 | 0.07% | 99.98% |
| Skin and Tegument | 8 | 0.02% | 100.00% |
| Total | 53,146 |